Fushida, S., Oyama, K., Kinoshita, J., Yagi, Y., Okamoto, K., Tajima, H., . . . Ohta, T. (2013). VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: Prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody. Dove Medical Press.
Chicago Stili AlıntıFushida, Sachio, Katsunobu Oyama, Jun Kinoshita, Yasumichi Yagi, Kouichi Okamoto, Hidehiro Tajima, Itasu Ninomiya, Takashi Fujimura, ve Tetsuo Ohta. VEGF Is a Target Molecule for Peritoneal Metastasis and Malignant Ascites in Gastric Cancer: Prognostic Significance of VEGF in Ascites and Efficacy of Anti-VEGF Monoclonal Antibody. Dove Medical Press, 2013.
MLA AlıntıFushida, Sachio, et al. VEGF Is a Target Molecule for Peritoneal Metastasis and Malignant Ascites in Gastric Cancer: Prognostic Significance of VEGF in Ascites and Efficacy of Anti-VEGF Monoclonal Antibody. Dove Medical Press, 2013.